A Phase I Clinical Study, Multiple Dose of LCB01-0371 in Healthy Male Subjects

Trial Profile

A Phase I Clinical Study, Multiple Dose of LCB01-0371 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2017

At a glance

  • Drugs LCB01-0371 (Primary)
  • Indications Bacterial infections; Gram-positive infections
  • Focus Adverse reactions
  • Sponsors LegoChem Biosciences
  • Most Recent Events

    • 23 Oct 2017 Results published in the Journal of Antimicrobial Chemotherapy
    • 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 07 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top